We are live on ! Find out more
GCIA

Gabelli & Co Investment Advisers Portfolio holdings

AUM $674M
1-Year Est. Return 64.46%
This Fund
S&P 500
This Quarter Est. Return
+14.52%
1 Year Est. Return
+64.46%
3 Year Est. Return
+233.2%
5 Year Est. Return
+564.06%
10 Year Est. Return
+5,311.56%
AUM
$651M
AUM Growth
-$10.4M
Cap. Flow
-$40.4M
Cap. Flow %
-6.21%
Top 10 Hldgs %
33.34%
Holding
313
New
62
Increased
51
Reduced
31
Closed
48

Top Buys

Rank Stock Value
1
BPMC
Blueprint Medicines
BPMC
+$19M
2
SKX
Skechers
SKX
+$16.5M
3
SWTX
SpringWorks Therapeutics
SWTX
+$12.6M
4
WBA
Walgreens Boots Alliance
WBA
+$9.26M
5
DNB
Dun & Bradstreet
DNB
+$7.98M

Top Sells

Rank Stock Value
1
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$26.7M
2
FNA
Paragon 28, Inc.
FNA
+$18.3M
3
BECN
Beacon Roofing Supply, Inc.
BECN
+$18M
4
DFS
Discover Financial Services
DFS
+$16.7M
5
DESP
Despegar.com
DESP
+$12.8M

Sector Composition

Rank Sector Weight
1 Healthcare 17.22%
2 Communication Services 15.3%
3 Technology 11.49%
4 Industrials 8.49%
5 Consumer Discretionary 8.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LLYVK icon
51
Liberty Live Group Series C
LLYVK
$9.61B
$2.84M 0.44%
35,054
+9,513
+37% +$702K
TMUS icon
52
T-Mobile US
TMUS
$192B
$2.74M 0.42%
11,500
– –
NVEE
53
DELISTED
NV5 Global
NVEE
$2.7M 0.41%
+116,900
New +$2.34M
OYSEU
54
Oyster Enterprises II Acquisition Corp Units
OYSEU
$2.54M 0.39%
+250,700
New +$2.53M
BRSL
55
Brightstar Lottery PLC
BRSL
$2.08B
$2.53M 0.39%
160,203
+61,672
+63% +$969K
MAG
56
DELISTED
MAG Silver
MAG
$2.51M 0.39%
+118,999
New +$2.12M
PVBC
57
DELISTED
Provident Bancorp
PVBC
$2.5M 0.38%
+200,000
New +$2.27M
INZY
58
DELISTED
Inozyme Pharma
INZY
$2.47M 0.38%
+617,000
New +$1.53M
CGCTU
59
DELISTED
Cartesian Growth Corp III Unit
CGCTU
$2.47M 0.38%
+243,600
New +$2.45M
SPWH icon
60
Sportsman's Warehouse
SPWH
$46.8M
$2.36M 0.36%
685,080
-83,558
-11% -$187K
LWAY icon
61
Lifeway Foods
LWAY
$454M
$2.34M 0.36%
94,746
+33,800
+55% +$801K
JACS
62
Jackson Acquisition Co II
JACS
$2.27M 0.35%
+220,100
New +$2.24M
NFG icon
63
National Fuel Gas
NFG
$7.79B
$2.24M 0.34%
26,500
-500
-2% -$40.4K
KKR icon
64
KKR & Co
KKR
$99.4B
$2.18M 0.34%
16,400
– –
ESHA
65
DELISTED
ESH Acquisition Corp
ESHA
$2.17M 0.33%
197,600
– –
SRG
66
Seritage Growth Properties
SRG
$137M
$2.14M 0.33%
695,994
+9,000
+1% +$25.9K
PGAC
67
Pantages Capital Acquisition Corp
PGAC
$2.07M 0.32%
+203,200
New +$2.05M
SAGE
68
DELISTED
Sage Therapeutics
SAGE
$2.05M 0.31%
+224,450
New +$1.65M
GHC icon
69
Graham Holdings Company
GHC
$4.96B
$1.98M 0.3%
2,097
-25
-1% -$23.6K
TSAT icon
70
Telesat
TSAT
$900M
$1.93M 0.3%
79,161
+5,100
+7% +$89.5K
FERAU
71
Fifth Era Acquisition Corp I Units
FERAU
$1.81M 0.28%
174,500
– –
GGT
72
Gabelli Multimedia Trust
GGT
$175M
$1.79M 0.27%
432,582
– –
ETWO
73
DELISTED
E2open Parent Holdings
ETWO
$1.75M 0.27%
+542,050
New +$1.43M
AVGO icon
74
Broadcom
AVGO
$1.97T
$1.71M 0.26%
6,215
– –
SSYS icon
75
Stratasys
SSYS
$775M
$1.64M 0.25%
142,604
– –
1 2
3
4 5

Similar funds

RCM
Redwood Capital Management New York $674M AUM 99.78% 1-Year Est. Return
DPC
Dream Peak Capital Hong Kong $675M AUM
BFA
Blueprint Financial Advisors Greensboto, North Carolina $675M AUM 24.91% 1-Year Est. Return
CCM
Corsair Capital Management New York $673M AUM 109.99% 1-Year Est. Return
CHCM
Columbus Hill Capital Management Short Hills, New Jersey $673M AUM 24.63% 1-Year Est. Return
JC
JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return
NI
Noked Israel Ramat Hasharon, Israel $677M AUM 69.37% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return

Gabelli & Co Investment Advisers's Q2 2025 Portfolio in Review

As of Q2 2025, Gabelli & Co Investment Advisers held 313 positions worth $651M, down 1.6% from $662M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Gabelli & Co Investment Advisers withdrew a net $40.4M in Q2 2025, closing 48 positions and reducing 31 holdings. Its most notable exit was Intra-Cellular Therapies Inc., an estimated $26.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Communication Services and Technology.

Against the trend, Gabelli & Co Investment Advisers opened a new position in Blueprint Medicines worth $23.5M.

  • Gabelli & Co Investment Advisers's largest Q2 2025 buy was Blueprint Medicines: 183,374 shares worth $23.5M.
  • Gabelli & Co Investment Advisers added most to SpringWorks Therapeutics in Q2 2025, an estimated $12.6M increase.
  • Gabelli & Co Investment Advisers's biggest Q2 2025 reduction was Albertsons Companies, cutting an estimated $4.03M.
  • Gabelli & Co Investment Advisers fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $26.7M.
  • Gabelli & Co Investment Advisers's ten largest holdings make up 33% of its $651M portfolio in Q2 2025.
  • Gabelli & Co Investment Advisers opened 62 new positions and closed 48 in Q2 2025.
  • Gabelli & Co Investment Advisers's portfolio value fell 1.6% quarter-over-quarter to $651M.

Based on Gabelli & Co Investment Advisers's 13F filing for Q2 2025, filed 13 Aug 2025.